VANGUARD BD INDEX FDS - INTERMED TERM (BIV)

Historical Holders from Q1 2014 to Q3 2025

Symbol
BIV
Type / Class
Equity / INTERMED TERM
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
202,826,011
Holdings value
$15,836,081,050
% of all portfolios
0.11%
Number of holders
912
Number of buys
510
Number of sells
-330
Average buys %
+0.01%
Average sells %
-0.01%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of VANGUARD BD INDEX FDS - INTERMED TERM (BIV)

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q3 202,826,011 $15,836,081,050 +$1,407,485,695 $78.09 912
2025 Q2 191,277,241 $14,787,180,384 +$379,178,589 $77.34 924
2025 Q1 186,420,550 $14,268,829,633 +$1,039,958,668 $76.57 913
2024 Q4 173,006,633 $12,926,998,167 +$1,046,283,723 $74.73 927
2024 Q3 157,275,509 $12,316,768,127 +$606,439,170 $78.37 853
2024 Q2 149,476,914 $11,195,921,608 +$337,789,410 $74.89 822
2024 Q1 143,425,804 $10,808,812,217 +$35,655,814 $75.40 810
2023 Q4 144,262,463 $11,014,236,772 +$684,403,799 $76.38 818
2023 Q3 133,141,565 $9,627,094,648 +$243,656,903 $72.31 714
2023 Q2 127,037,508 $9,557,694,775 +$971,445,128 $75.23 716
2023 Q1 113,878,582 $8,739,411,864 +$497,622,285 $76.74 696
2022 Q4 108,012,062 $8,033,212,252 +$187,478,725 $74.32 679
2022 Q3 104,737,659 $7,696,712,301 +$1,112,288,871 $73.48 648
2022 Q2 89,628,353 $6,961,558,651 -$95,790,955 $77.65 667
2022 Q1 90,826,478 $7,432,195,757 -$60,691,479 $81.90 709
2021 Q4 91,042,492 $7,973,531,648 -$159,411,788 $87.62 718
2021 Q3 90,259,186 $8,073,952,254 +$295,603,261 $89.44 633
2021 Q2 87,359,609 $7,859,665,300 +$33,326,860 $89.96 629
2021 Q1 87,026,680 $7,721,919,902 -$763,921,919 $88.73 618
2020 Q4 95,523,018 $8,861,879,486 +$129,073,414 $92.85 646
2020 Q3 92,563,538 $8,651,776,731 +$1,009,584,375 $93.48 558
2020 Q2 82,338,817 $7,674,096,313 +$343,990,302 $93.19 524
2020 Q1 78,521,353 $7,013,125,600 -$2,109,703,330 $89.33 492
2019 Q4 101,934,764 $8,892,378,892 +$357,549,741 $87.22 478
2019 Q3 96,856,049 $8,521,961,839 -$2,033,740 $88.00 408
2019 Q2 97,001,370 $8,390,242,503 +$276,443,357 $86.50 419
2019 Q1 93,889,695 $7,880,324,794 -$1,812,798,605 $83.93 396
2018 Q4 115,082,601 $9,353,825,084 +$417,478,235 $81.29 402
2018 Q3 109,174,437 $8,785,690,679 -$644,815,847 $80.48 377
2018 Q2 117,045,107 $9,476,936,370 -$1,254,111,385 $80.97 380
2018 Q1 132,541,695 $10,830,696,907 +$277,586,117 $81.77 396
2017 Q4 129,099,534 $10,822,187,538 +$601,284,541 $83.83 401
2017 Q3 121,234,044 $10,263,398,945 +$3,372,239,232 $84.66 345
2017 Q2 81,289,296 $6,872,027,848 -$616,730,294 $84.53 333
2017 Q1 88,635,504 $7,411,404,498 +$727,701,573 $83.61 331
2016 Q4 79,983,817 $6,644,757,157 -$755,260,277 $83.07 324
2016 Q3 88,446,023 $7,751,884,559 +$360,871,684 $87.66 312
2016 Q2 84,485,584 $7,440,184,494 +$1,121,225,131 $88.07 295
2016 Q1 71,456,812 $6,163,399,159 +$454,558,302 $86.27 276
2015 Q4 66,069,381 $5,488,700,296 +$805,593,335 $83.06 263
2015 Q3 54,689,496 $4,628,377,574 +$1,846,356,101 $84.84 231
2015 Q2 47,230,026 $3,963,229,498 +$268,826,566 $83.87 223
2015 Q1 44,017,564 $3,794,557,057 +$712,465,716 $86.21 218
2014 Q4 35,735,009 $3,026,453,213 +$153,786,036 $84.68 201
2014 Q3 31,200,980 $2,629,189,598 +$237,239,398 $84.26 175
2014 Q2 28,380,575 $2,403,542,831 +$449,008,107 $84.69 170
2014 Q1 23,077,751 $1,922,859,596 -$412,500,077 $83.33 161